The Division of Cardiovascular Medicine has a long and distinguished history of excellence in patient care, research and education. Our ongoing programs continue that tradition, and we are very excited about our future.

The Division of Cardiovascular Medicine plays an important role in the mission of MU Health Care and the Harry S. Truman Memorial Veterans’ Hospital.

Our first mission is to heal. We have busy cardiac intensive care unit, ward and consultative services, where our dedicated team of doctors and nurses provide excellent medical care. Our cardiac catheterization laboratories, electrophysiology laboratory and non-invasive cardiology laboratories have state-of-the-art technology and provide a full range of diagnostic and therapeutic services. Our quality is monitored by a variety of national standards including the American College of Cardiology Cardiac Catheterization Database.

Our second mission is to teach. Cardiovascular Medicine conferences take place daily Monday through Friday. Cardiovascular Medicine Grand Rounds provide a comprehensive review of new developments in the field and are presented by both department and visiting faculty. The Cardiology Case Conference brings cardiologists and cardiothoracic surgeons together to solve cardiac challenges in patients with coronary artery disease and valvular heart disease. ECG interpretation by senior faculty is a popular teaching venue for medical students and residents in the division.

Our third mission is to discover. We take part in many clinical trials involving a wide range of cardiovascular diseases. At the basic and translational science level our faculty are interested in thrombosis, angiogenesis, exercise and many other relevant topics. Our faculty regularly present at national meetings and are considered opinion leaders in a number of areas including the management of myocardial infarction, cardiac arrhythmias, obesity and the heart and cardiomyopathies.

Edward Yeh and

Research

MU Division of Cardiovascular Medicine faculty members are actively engaged in research, with projects ranging from NIH-sponsored basic science studies of vascular biology to multi-center clinical trials examining the efficacy of new cardiovascular treatment modalities.